Related Experiment Video
Updated: May 14, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
[Expression of thrombomodulin in malignant pleural mesothelioma]
M Amati1, I Nocchi, M Tomasetti
1Dipartimento di Patologia Molecolare e Terapie Innovative, Clinica Medicina del Lavoro, Universith Politecnica delle Marche, via Tronto 10/A 60020 Torrette, Ancona. m.amati@univpm.it
Abstract:
The malignant mesothelioma (MM) is often complicated by thromboembolic episodes, with thrombomodulin (TM) playing a role in the anti-coagulant process. We analyzed TM expression in biopsies of MM patients and in normal mesothelial tissue. The role of DNA methylation-associated gene silencing in TM expression was investigated. A correlation between low TM expression and high level of TM promoter methylation was found in MM biopsies. Low expression of TM was restored in MM cells by their treatment with 5-aza-2'-deoxycytidine while the epigenetic agent did not affect TM expression in Met-5A cells. Methylation of the TM promoter is responsible for silencing of TM expression in MM tissue.
Related Concept Videos
Pleural Disorders: Types and Brief Description
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

